Vaxcyte (PCVX) Payables (2019 - 2026)
Vaxcyte (PCVX) recorded Payables of $67.61 million in Q3 2026, up 38.1% from $48.96 million a year earlier but down 33.0% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte reported Payables of $70.9 million, up 46.3% from FY2024.
- Annual Payables has increased for four straight years, with a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- Across earlier years, Payables came in at $48.45 million in FY2024 (+232.2%), $14.59 million in FY2023 (+48.9%), $9.8 million in FY2022 (+44.9%) and $6.76 million in FY2021 (-77.3%).
- Quarterly Payables has ranged from $4.8 million in Q1 2022 to $100.92 million in Q2 2026 over the past five years.
- On a year-over-year basis, Payables has increased for six consecutive quarters, with growth averaging 138.6% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 232.2% in Q4 2024, against a decline of 84.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $100.92 million (Q2 2026), $63.06 million (Q1 2026) and $70.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | 67.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 67.61 Mn |
| Jun 30, 2026 | 100.92 Mn |
| Mar 31, 2026 | 63.06 Mn |
| Dec 31, 2025 | 70.90 Mn |
| Sep 30, 2025 | 48.96 Mn |
| Jun 30, 2025 | 31.41 Mn |
| Mar 31, 2025 | 20.51 Mn |
| Dec 31, 2024 | 48.45 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 21.72 Mn |
| Dec 31, 2023 | 14.59 Mn |
| Sep 30, 2023 | 15.70 Mn |
| Jun 30, 2023 | 16.27 Mn |
| Mar 31, 2023 | 11.62 Mn |
| Dec 31, 2022 | 9.80 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 6.76 Mn |
API Access
Vaxcyte Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();